RMD
Resmed Inc
2 super-investors hold RMD worth a combined $126M. The largest position: Francois Rochon at 1.9% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 27 — ranked #486 of 724 scored stocks.
Why super-investors own RMD
Interest in RMD within this cohort remains thin and static: only two managers carry a position, and neither added nor trimmed in 2026Q1. Francois Rochon holds the more meaningful stake at 1.9% of his portfolio ($52M), while Joel Greenblatt's $75M position represents just 0.1% of his — suggesting it is more of a quantitative or incidental holding than a high-conviction bet. The owner count history tells a clear story: the stock was absent from cohort portfolios until appearing in one fund two quarters ago, and has not attracted any new entrants since. At a combined $126M across two holders, super-investor engagement with RMD is minimal and showing no signs of broadening.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2020Q3 → 2026Q1How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | 0.1% | 38q | $75M | 332,108 |
| 2 | Francois Rochon | 1.9% | 13q | $52M | 230,005 |
Owners of RMD also hold
Long US equity 13F-HR filings only. CUSIP 761152107. Not investment advice.